Mayo Clinic Talks

This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021 Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) People may be curious, confused or critical of what seem to be changing messages related to the COVID-19 pandemic. Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, reminds folks that messages change because data changes and the science evolves. "As we learn new science, we use that science to modify our recommendations," says Dr. Poland. "It's not that scientists are flip-flopping. It is that new data allows us to begin expanding those recommendations." For instance, COVID-19 cases and deaths in the U.S. are currently declining. But, Dr. Poland says, there are new data predicting the possibility of another surge of COVID-19 infections in March because of U.K. variant transmission. In this Mayo Clinic Q&A podcast Dr. Poland talks about several issues, including the U.K. variant, vaccine development and the public’s COVID-19 fatigue. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Ravindra Ganesh, M.B.B.S., M.D. and Raymund R. Razonable, M.D. Host: Amit K. Ghosh, M.D. (@AmitGhosh006) In this episode, Ravindra Ganesh, M.B.B.S., M.D. and Raymund R. Razonable, M.D. join Amit K. Ghosh, M.D. to review the use of monoclonal antibody as a new antiviral agent in the treatment of COVID-19 infection. Who is most likely to benefit from monoclonal antibody infusions? Drs. Ganesh and Razonable, discuss recent studies on monoclonal antibody infusions in patients with mild to moderate COVID-19 infections. Also discussed are the logistical challenges faced and the innovative solutions that were implemented while administering this therapy, particularly navigating the acceptance of treatment, its real and perceived side effects, and lack of awareness due to inequity and poverty. Research on the development of subcutaneous or intramuscular administration for prophylaxis against COVID-19 in patients at high risk for complications or at high risk for being exposed to SARS-CoV-2 is also discussed in this episode. Additional resources: AskMayoExpert COVID-19 Navigator: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Weinreich DM, Sivapalasingam S, Norton T, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med 2021;384:238-251. Chen P, Nirula A, Heller B, et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19. N Engl J Med 2021;384:229-237. Gottlieb RL, Nirula A, Chen P, et al. Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.JAMA. Published online January 21, 2021. doi:10.1001/jama.2021.0202 An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19. JAMA. Published online December 11, 2020. doi:10.1001/jama.2020.24415 Monoclonal Antibodies: Update on this COVID-19 Experimental Therapy https://discoverysedge.mayo.edu/2021/02/17/monoclonal-antibodies-update-on-this-covid-19-experimental-therapy/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Greg Vanichkachorn, M.D., M.P.H. Host: Amit K. Ghosh, M.D. (@AmitGhosh006) For some patients who have had COVID-19, symptoms of the disease may last long after the infection is over. Long-haulers syndrome due to COVID-19 could include profound fatigue, shortness of breath, and long-term neurological complaints, including headache, dizziness, or weakness. Mayo Clinic has launched the COVID Activity Rehabilitation Program, or CARP, to help these patients return to daily life and work. CARP is not just for folks who are trying to get back to work, but for anyone trying to get back to their baseline life. In this episode, Dr. Greg Vanichkachorn, a Mayo Clinic preventive, occupational and aerospace medicine specialist who leads the CARP program, gives an overview of COVID long haulers and how post-COVID symptoms affects patients. He also shares the goals and results of Mayo Clinic CARP program. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Answers from the Lab and was originally published February 2, 2021. Guest: Matthew J. Binnicker, Ph.D. (@DrMattBinnicker) Host: William G. Morice, II M.D., Ph.D. (@moricemdphd) Matthew Binnicker, Ph.D., vice chair of practice for Mayo Clinic's Department of Laboratory Medicine and Pathology, joins William Morice II, M.D., Ph.D., president of Mayo Clinic Laboratories, for this week's "Answers From the Lab" leadership update. In this episode, Dr. Binnicker and Dr. Morice discuss the impact that emerging COVID-19 variants could have on virus testing, vaccine and spread. For more, follow the Mayo Clinic Labs on Twitter @mayocliniclabs or visit https://news.mayocliniclabs.com/podcast/answers-from-the-lab/ to check out all of their episodes.

Guest: Ravindra Ganesh, M.B.B.S., M.D. Host: Amit K. Ghosh, M.D. (@AmitGhosh006) The Mayo Clinic COVID Frontline Healthcare Team (CFCT) is an integrated team comprised of doctors and support staff, including nurses, remote monitoring technicians, medical assistants, and desk staff. These teams are responsible for evidence-based management of all newly diagnosed COVID-19 patients. We’re joined by CFCT Codirector Ravindra Ganesh, M.B.B.S., M.D., to discuss the essential roles of CFCT’s during the pandemic. Topics include how they: Notify all patients who receive a COVID positive test result in Mayo/Mayo Clinic Health service in the Midwest region through phone call or portal messaging with attached questionnaire Conduct outpatient monitoring and follow-up as well as identify patient at high risk for decompensation Prevent COVID positive patients from coming to the Mayo Clinic facilities by remote monitoring and risk assessment Reinforce social isolation recommendations from public health to all COVID positive patients and assess safety to come off isolation Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021 To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: David B. Soma, M.D. (@DrDaveSoma); Talha Niaz, M.B.B.S. Host: Angela C. Mattke, M.D. (@DrAngelaMattke) There are many benefits to sports participation for children and adolescents. However, during the COVID-19 pandemic, activities such as youth sports have been put on hold or modified to decrease the spread of COVID-19. Also, the scientific community is learning about when it is safe to return to sports participation following COVID-19 infection. On the Mayo Clinic Q&A podcast, "Ask the Mayo Mom" host and Mayo Clinic pediatrician, Dr. Angela Mattke is joined by Dr. David Soma, a pediatric sports medicine physician at Mayo Clinic Children's Center, to discuss sports participation during the COVID-19 pandemic and what you need to know about return to play after COVID-19 infection. Also joining Drs. Mattke and Soma is Dr. Talha Niaz, a pediatric cardiologist at Mayo Clinic. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021 To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Gregory A. Poland, M.D. (@DrGregPoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) When it comes to the COVID-19 pandemic, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, says there's some good news. "Case numbers are falling, masking and distancing do work, and we can control this if we do it right." However, the not so good news is that variants are showing up in over 30 countries and are reportedly more transmissible. There also seems to be a reduction in vaccine efficacy against the new variants. "This is a desperate race between vaccine and virus, between time and opportunity, and we dare not lose that opportunity," emphasizes Dr. Poland. In this Mayo Clinic Q&A podcast, Dr. Poland discusses how COVID-19 viruses mutate into new variants. He also discusses recent COVID-19 research conducted by the NFL, plus he touches on the future of individualized vaccines. "I can see the development of a coronavirus vaccine against multiple types of coronavirus, including the one that causes the common cold, and very likely combine that with the influenza vaccine." AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in January, 2021. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) The distribution kinks for COVID-19 vaccines are getting ironed out, says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "It's a logistics nightmare, but now you're seeing a plan to administer 1 million doses a day and I think that's very achievable," says Dr. Poland. "And the production of the vaccine is just going to accelerate." Dr. Poland also repeats the reminders about preventing transmission of COVID-19: Wear a mask. Wash your hands. Keep your social distance. "The current estimates are that in the next four weeks, we'll probably have about another 100,000 deaths," adds Dr. Poland. "It's stunning when you think about 1 out of every 860 Americans has now died of this." In this Mayo Clinic Q&A podcast, Dr. Poland talks more about the rollout, transmission and herd immunity, as well as fertility issues related to COVID-19, survivor brain fog and more. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Patricio Gargollo, M.D. (@pgargollo) Host: Darryl S. Chutka, M.D. (@ChutkaMD) Enuresis is relatively common in children, estimated to be present in as many as 5 to 10% of 7-year-olds. This represents up to 7 million children in the United States. As you can imagine, it carries significant social implications for the child. Our guest for this podcast is Dr. Patricio Gargollo, a pediatric urologist at Mayo Clinic in Rochester, Minnesota. Dr. Gargollo will address the natural history of enuresis, how to evaluate the child with enuresis, how often it represents a structural urologic problem and how often a treatable cause is found. Practical advice for parents of children with enuresis is also discussed. Specific topics: Potential for children with enuresis to have bladder control problems when they develop into adulthood. Social impact of enuresis on a child. Potential risk factors and causes of enuresis. The role of genetics and enuresis. The natural history of enuresis. How often a structural urologic problem is found to explain enuresis. Pharmacologic treatment options. The evaluation of a child with enuresis. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Answers from the Lab and was originally published January 28, 2021. Guest: William G. Morice, II M.D., Ph.D. (@moricemdphd) Host: Bobbi S. Pritt, M.D. (@ParasiteGal) William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the new nationwide strategy that the Biden administration is rolling out to combat COVID-19. For more, follow the Mayo Clinic Labs on Twitter @mayocliniclabs or visit https://news.mayocliniclabs.com/podcast/answers-from-the-lab/ to check out all of their episodes.

Guest: Eric J. Cleveland; Danielle M. Teal (@dteal) Host: Amit K. Ghosh, M.D. (@AmitGhosh006) Joy has been defined as a human emotion — a state created as we experience positive, poignant, reflective and connective moments. It is transient, never persisting but imparting ripples that impact us long after the moment. Now more than ever there is a need to develop mindful initiatives that brings joy in our personal lives and in the workplace. In this episode we speak with Eric Cleveland and Danielle Teal, two leaders of the Joy at Mayo Clinic (J@M) initiative. We will discuss the joy equation, the Institute of Health Improvement’s (IHI) Framework for Improving Joy in Work and discuss examples of pragmatic initiatives that can bring joy at both the individual and team levels. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded on January 11, 2021. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) The U.S. rollout of COVID-19 vaccines is reportedly ramping up with news that nearly all available doses will soon be released to the American public. "The new COVID-19 variants are traveling quickly, and this is a warning that we need to take precautions," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. Dr. Poland says these new variants are a consequence of an RNA virus being transmitted from human to human. "Even after we get our vaccines, we still need to wear masks out in public. We still need to maintain physical distancing. And we still need to wash our hands until about 80% of people get their COVID-19 vaccines," Dr. Poland emphasizes.In this Mayo Clinic Q&A podcast, Dr. Poland goes into detail about the COVID-19 vaccines, including "sterilizing immunity," testing for antibodies after receiving the vaccine, the possibility of booster doses in the future and much more. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Leslie A. Sim, Ph.D., L.P. (@DrLeslieSim) Host: Darryl S. Chutka, M.D. (@ChutkaMD) A variety of eating disorders can occur in adults and they are associated with multiple potential health complications, including an increased risk of death. Some studies report that up to 20% of those with Anorexia Nervosa will die as a result of the condition. Would you recognize an eating disorder in the patients you see? What clues should you look for? In this week’s Mayo Clinic Talks, we’ll speak with Dr. Leslie Sim, a psychologist at the Mayo Clinic. We’ll discuss who is most likely to develop an eating disorder, important “red flag” symptoms, questions you should ask patients to help confirm a diagnosis, and how we should approach a patient we suspect has an eating disorder. Topics discussed: Definition of an eating disorder Important “red flag” symptoms that may indicate an eating disorder Health complications that can occur as a result of an eating disorder Who is most likely to have an eating disorder The genetic component to eating disorders Clues from their childhood that suggest patients may have an eating disorder as an adult Events which can trigger an eating disorder When we should suspect an eating disorder How we should approach a patient we suspect has an eating disorder Management of eating disorders Effectiveness of treatment Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in January, 2021. Guests: Emily R. Levy, M.D. (@EmilyLevy797); Nipunie S. Rajapakse, M.D., M.P.H. (@nrajapakseMD) Host: Angela C. Mattke, M.D. (@DrAngelaMattke) Around the world, COVID-19 vaccinations are underway, but only in adults. Pfizer's vaccine has been authorized for ages 16 and up, while Moderna's vaccine is currently authorized for ages 18 and up. Vaccines are generally tested in adults first to ensure they are safe for pediatric trials. Both Pfizer and Moderna now have clinical trials underway to study the safety and effectiveness of COVID-19 vaccines in children. This edition of the Mayo Clinic Q&A podcast features an #AskMayoMom episode hosted by Dr. Angela Mattke, a pediatrician at Mayo Clinic Children's Center. Joining Dr. Mattke to discuss COVID-19, vaccines and children are Dr. Nipunie Rajapakse, a Mayo Clinic pediatric infectious diseases physician, and Dr. Emily Levy, a Mayo Clinic pediatric critical care and infectious diseases expert. Dr. Levy also discusses multisystem inflammatory syndrome in children, also known as MIS-C. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Corey M. Kunzer, P.T., D.P.T., SCS, (@KunzerCorey) and Edward R. Laskowski, M.D. (@DrEdSportsMed) Host: Darryl S. Chutka, M.D. (@ChutkaMD) Over the past decade more individuals have begun working remotely; the numbers have increased dramatically this past year with the COVID-19 pandemic. While there are some advantages to working remotely, there are also some potential problems associated with it. Those working from home often develop a variety of musculoskeletal problems including low back and neck pain, as well as shoulder and extremity discomfort. Drs. Edward Laskowski, a physician and Corey Kunzer, a physical therapist, both in the Department of Physical Medicine and Rehabilitation at the Mayo Clinic will discuss some of the musculoskeletal problems associated with working remotely. Specific topics discussed: Frequency of musculoskeletal problems associated with working from home Differences between working at home vs. the traditional office Issues to consider when selecting a desk and chair Recommended positions of the monitor, keyboard and mouse Benefits of a standing workstation or working while walking on a treadmill Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Andrew Jagim, Ph.D. (@AJagim) Host: Darryl S. Chutka, M.D. (@ChutkaMD) Billions of dollars per year are spent in the U.S. on nutritional supplements to enhance performance. Multiple nutritional supplements are commercially available and are marketed for enhancing endurance, building muscle strength, improving exercise efficiency, and decreasing the potential for injury. Do these supplements actually deliver the benefits they claim? Are they safe? What age athletes are taking these supplements? We’ll discuss these topics and more with Dr. Andrew Jagim, the director of sports medicine research at the Mayo Clinic. Specific topics: Recommended approach to the athlete who wants to improve their performance Potential benefits of nutritional supplements for athlete's Age of athletes taking nutritional supplements Selecting a high-quality nutritional supplement Reliable web sites reviewing the available nutritional supplements including potential benefits and safety Review of commonly taken nutritional supplements Nutritional supplements which have potential harm Additional Resources: Mayo Clinic Proceedings Article: https://www.mayoclinicproceedings.org/article/S0025-6196(20)30363-3/fulltext NIH – Office of Dietary Supplements: https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/ International Society of Sports Nutrition (ISSN): https://www.sportsnutritionsociety.org/ Third-Party Testing Information: https://examine.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. Guest: Tyler Oesterle, M.D., M.P.H. (@OesterleMD) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) Stress, isolation and limited access to resources are fueling rising rates of substance abuse and overdoses during the COVID-19 pandemic. While coronavirus has been the focus of so much attention this year, the opioid crisis has continued unabated and has even worsened. More than 40 states have reported increases in opioid related deaths, according to the American Medical Association. On the Mayo Clinic Q&A podcast, Dr. Tyler Oesterle, a psychiatrist and addiction expert at Mayo Clinic, discusses opioid use disorders and treatment options, including virtual medicine available during the pandemic. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. Guest: John (Jack) C. O'Horo, M.D., M.P.H. (@jcohoro) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) A recent Mayo Clinic study published in Mayo Clinic Proceedingsfound that patients with COVID-19 who received care at Mayo Clinic had lower mortality rates than the national average. Mayo Clinic patients were treated using an integrated, team-based approach for patient monitoring and treatment. On the Mayo Clinic Q&A podcast, Dr. John O'Horo, a Mayo Clinic infectious diseases physician and the study's first author, discusses the study results and explains how the Mayo Clinic Model of Care improves outcomes for patients. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Alisha Morgan, D.O. (@AAMORGAN_DO) Host: Darryl S. Chutka, M.D. (@ChutkaMD) It’s estimated that there may be over 30 million individuals in the U.S. who provide ongoing care to older adults, half of these to family members with some form of dementia. The majority of these caregivers are female and a significant percentage of these caregivers have their own major health problems. This has become a major social and economic issue in the care of our geriatric patients. Dr. Alisha Morgan, a family medicine and hospice physician at the Mayo Clinic joins us to address the challenges associated with being a caregiver, how healthcare providers should assess caregiver burden, potential financial resources available to assist caregivers, and interventions to reduce the impact of stress on caregivers. Specific topics: Morbidity and mortality of care givers The amount of time caregivers devote to assisting older adults Financial burden of providing chronic care to older adults How primary care providers should acknowledge caregivers How primary care providers should evaluate How caregiver stress should be provided Available financial resources for caregivers Caregiver Resources: https://www.aarp.org/content/dam/aarp/entertainment/books/2015-04/Caregivers_Excerpt.pdf Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode was recorded on December 18, 2020. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) It is projected that by March of 2021 1:700 Americans will have died of COVID-19. The historic pace of COVID-19 vaccine development was made possible by the countless sacrifices of many individuals across healthcare, research, health and human services, the Department of Defense, and other key sectors. This interprofessional collaboration required many to set life aside and work tirelessly to bring an effective vaccine to market, quickly. While mRNA vaccines have been in development since the 1990s, the COVID-19 vaccine efficacy rate of 95-100% across studied ages, race and ethnicities, and comorbidities is unprecedented. The questions left to answer are, how long will the efficacy last? In larger population studies, what is the safety/allergy/hypersensitivity profile? What impact does the vaccine have on asymptomatic carrier spread? Who shouldn’t get the vaccine? Dr. Greg Poland breaks down everything you need to know about the mRNA COVID-19 vaccines. Additional Resources: Mayo Clinic Vaccine Research Page https://www.mayo.edu/research/labs/vaccine-research-group/overview Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education https://www.sciencedirect.com/science/article/pii/S0264410X11011881 AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Matthew L. Carlson, M.D. (@MatthewLCarlso1) Host: Darryl S. Chutka, M.D. (@ChutkaMD) Issues surrounding hearing loss are discussed with Dr. Matthew Carlson, an ENT physician from the Mayo Clinic. Specific topics discussed include the following: Types of hearing loss (conductive vs. sensorineural) Social impact of hearing loss Symptoms patients notice with gradually progressive hearing loss Tinnitus and it’s management Causes of sensorineural hearing loss High frequency tone loss and problems with speech discrimination associated with sensorineural hearing loss Hearing loss associated with loud noise exposure (acoustic injury and chronic noise exposure) Hearing loss associated with the use of firearms Common everyday activities which may result in hearing loss Management of sensorineural hearing loss (hearing aids, cochlear implants) Recent advances and improvements in hearing aids Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode was recorded on October 23, 2020. Guest: Robert M. Jacobson, M.D. (@RobertJMD) Host: Darryl S. Chutka, M.D. (@ChutkaMD) It’s estimated that immunizations have saved more lives and prevented more disabilities than any other medical intervention. They’re also extremely cost effective and their benefits far outweigh the very small risks they carry. Yet there are individuals who choose to believe that immunizations are potentially harmful. Our guest for this podcast is Dr. Robert Jacobson, a Mayo Clinic pediatrician and expert in the field of immunizations. We cover topics including an update on the COVID-19 vaccine and when it will realistically be available on a large scale for the population. Other important issues discussed include which vaccines are important for children and adults and whether it’s safe to administer multiple vaccines at one time. Finally, many of the concern promoted by the anti-vaccine movement are discussed and dispelled. Specific topics discussed: Variety of vaccines in development for COVID-19 Novel techniques being use in the development of the COVID-19 vaccine Timing on the availability of the COVID-19 vaccine Important immunizations for children Important immunizations for adults Anti-vaccine concerns and myths surrounding vaccines Updates on the age recommendations for the HPV vaccine Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) The first COVID-19 vaccines to reach the market are likely to be messenger RNA vaccines, or mRNA. According to the Centers for Disease Control and Prevention, mRNA vaccines work by teaching cells in the body how to make a protein that triggers an immune response. Unlike many vaccines that use a weakened or inactivated form of a virus, mRNA vaccines do not use the live virus that causes COVID-19. On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains how mRNA vaccines work, gives a status update on the pandemic and answers listener questions. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in November, 2020. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Elie F. Berbari, M.D. Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar) The current COVID-19 surge numbers could worsen in coming days as experts prepare for a post-Thanksgiving holiday increase in cases. Increased positivity rates lead to more people needing hospitalization, straining the health care system and medical staff. On the Mayo Clinic Q&A podcast, Dr. Elie Berbari, chair of the Division of Infectious Diseases at Mayo Clinic, explains how Mayo Clinic is managing staff, supplies and space during the COVID-19 surge. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Darryl S. Chutka, M.D. (@ChutkaMD) Many of us learned how to wash our hands at a very early age and have relearned the importance and proper technique periodically along the way. Research suggests that many people may not be doing it correctly. Dr. Greg Poland a Professor of Medicine in Infectious Disease at the Mayo Clinic joins us for National Hand Washing Awareness Week to discuss some tips and tricks to share with your patients to ensure they’re reaching the full potential of this life-saving technique. He’ll also answer questions like does it matter if the water is hot? Is handwashing with soap more effective than anti-bacterial gel or lotions? And, when should we be washing our hands? Additional resources mentioned (not an endorsement or affiliation): Glo Germ: Visual Tool for Handwashing https://www.glogerm.com/ Jimmy Kimmel and Guillermo Learn How to Wash Their Hands https://youtu.be/sJfsyhQ0oBs Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode was recorded on November 17th, 2020. Guest: Raymund R. Razonable, M.D. (@RazonableMD) Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) What causes some patients to develop Long Haul COVID-19? Dr. Raymund Razonable discusses what the current data is showing and what we’re hoping to learn from future research. Deeper dive: As Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts https://jamanetwork.com/journals/jama/fullarticle/2771111 AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Joseph A. Murray, M.D. Host: Darryl S. Chutka, M.D. (@ChutkaMD) The diagnosis and management of Celiac Disease is discussed with Dr. Joseph Murray, a gastroenterologist from the Mayo Clinic. Specific topics discussed include: Typical presentations of Celiac Disease in children and adults Difficulties encountered in establishing a diagnosis Small bowel pathology seen in Celiac Disease Mechanism for malabsorption in Celiac Disease Risk factors for Celiac Disease Celiac Disease and pregnancy How to confirm a diagnosis of Celiac DiseaseLaboratory tests Necessity of a small bowel biopsy Management of Celiac Disease Challenges in maintaining a gluten-free diet Potential long-term complications of Celiac Disease Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: John J. Poterucha, M.D. Host: Darryl S. Chutka, M.D. (@ChutkaMD) The topic of Hepatitis C, including risk factors, evaluation and management was discussed with Dr. John Poterucha, a gastroenterologist from the Division of Gastroenterology and Hepatology. Specific topics discussed include: Serologic testing for hepatitis C Symptoms of hepatitis C Risk factors for hepatitis C Transmission of hepatitis C during pregnancy Risk of hepatitis C transmission following a needle-stick exposure Identifying which patients should be tested for hepatitis C Natural history of hepatitis C Potential complications of hepatitis C Available pharmacologic treatment Potential for reinfection with hepatitis C Hepatitis C and liver transplantation Potential for an effective hepatitis C vaccine Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in November, 2020. Guest: William G. Morice, II, M.D., Ph.D. (@moricemdph) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) When the COVID-19 pandemic began, one of the areas of science and research most affected was laboratory medicine. From developing tests that detect the virus, to testing for antibodies in patients who have recovered, Mayo Clinic Laboratories has been at the forefront of COVID-19 testing and research. On the Mayo Clinic Q&A podcast, Dr. William Morice II, president of Mayo Clinic Laboratories and chair of the department of Laboratory Medicine and Pathology at Mayo Clinic, explains how a reference lab works and how Mayo Clinic Laboratories quickly ramped up its testing capability to meet pandemic testing needs. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Robert M. Jacobson, M.D. (@RobertJMD) Host: Darryl S. Chutka, M.D. (@ChutkaMD) It is extremely important that our patients receive the influenza vaccine this year. In previous years, less than half of the population has received it. Dr. Robert Jacobson, a pediatrician and vaccine specialist at the Mayo Clinic, joins us to discuss the reasons it’s so important for our patients to receive the influenza vaccine this season. He’ll share tips for discussing common concerns from vaccine-hesitant patients and how you can increase your patient vaccination rates. Specific topics discussed: Importance of the influenza vaccine for our patients in 2020/2021 How and when the influenza vaccine is developed for the next influenza season Why we need an influenza vaccine on an annual basis The best time of the year to receive the influenza vaccine Whether we lose some immunity to influenza if we receive the vaccine too early in the year Which vaccine should be given to those 65 years and older Common myths surrounding the influenza vaccine Predictions for the severity of influenza for 2020/2021 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Ericka E. Tung, M.D. Host: Darryl S. Chutka, M.D. (@ChutkaMD) The topic of Alzheimer’s Disease and other dementias was discussed along with the importance of providing care of the patient’s care-givers by Dr. Ericka Tung, a geriatrician in the Division of Community Internal Medicine at the Mayo Clinic. Specific topics discussed include: Common symptoms seen in early dementia. Mild cognitive impairment and its progression to dementia. Importance of stability of lifestyle in the life of patients with dementia. Discussing the diagnosis of dementia with the patient and family. Using a mental status exam in the evaluation of patients with suspected dementia. Establishing a diagnosis in patients with early dementia. The role of formal psychological testing in patients with suspected dementia. The needs of care-givers of dementia patients. Importance of respite care for the care-givers of dementia patients. Evaluating driving skills in patients with early dementia. Advanced care planning for dementia patients. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in October, 2020. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) The Centers for Disease Control and Prevention (CDC) has updated its guidelines for defining close contact with a person who is positive for COVID-19. Previously, close contact was defined as occurring when someone was within 6 feet of an infectious person for 15 consecutive minutes. Now close contact includes people who were within 6 feet for a total of 15 minutes over a 24-hour period, as the CDC now advises that repeated, brief encounters also carry a risk of transmission. On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, discusses the updated information from the CDC and the latest information from the Food and Drug Administration on COVID-19 treatments and vaccines. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Lewis J. Wesselius, M.D. Host: Darryl S. Chutka, M.D. (@ChutkaMD) The topic of COPD including risk factors, evaluation and management is discussed with Dr. Lewis Wesselius, a pulmonologist in the Division of Thoracic Disease at the Mayo Clinic. Specific topics discussed include the following: Review of the various types of COPD. Similarities and differences between emphysema and chronic bronchitis. Financial complications of COPD. Risk factors for COPD. Appropriate tests to order when evaluating patients suspected of having COPD. Determining the severity of COPD. Management of patients with COPD including the role of bronchodilators, inhaled corticosteroids, antibiotics and oxygen. COPD and the risk of lung cancer. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: James T C Li, M.D., Ph.D. (@jameslimd) Host: Darryl S. Chutka, M.D. (@ChutkaMD) The topic of anaphylaxis is reviewed including its causes, management and potential complications by James T C Li, M.D., Ph.D., an allergist from the Division of Allergic Disease from the Mayo Clinic. Specific topics discussed include the following: Truths vs. myths regarding anaphylaxis Common manifestations and presentations of anaphylaxis Triggers which more commonly produce an anaphylactic reaction Anaphylaxis in patients without a history of allergies When to use antihistamines in treating an allergic reaction When and how to prescribe epinephrine in treating patients with a history of allergic reactions Issues related to epinephrine auto-injectors Natural history of allergies over time Developments in peanut allergies Management of an anaphylactic reaction Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Christopher Camp, M.D. (@ChrisCampMD) Host: Darryl S. Chutka, M.D. (@ChutkaMD) The shoulder is unique in both structure and function. Injuries can occur acutely or overtime from wear and tear. If a patient presents with shoulder pain, when do you order imaging? What is role of steroid injections? When should a patient apply ice or apply heat? Dr. Christopher Camp, an orthopedist from Orthopedics and Sports Medicine at the Mayo Clinic joins us to discuss common injuries broken down by age demographic, treatment options, and when you may need to refer to a surgeon. The following topics are discussed: Anatomy of the shoulder joint and what makes it a unique joint. Injuries which commonly occur in both younger and older patients. Review of common pathologic conditions of the shoulder: Rotator cuff injuries Impingement syndrome Bursitis of the shoulder “Frozen shoulder” When a steroid injection of the shoulder is of benefit. When an X-ray or MRI of the shoulder is of benefit in the evaluation of shoulder pain. Benefits of physical therapy in patients with shoulder pain/injuries. The use of heat or cold in treating shoulder pain. When patients should be referred to an orthopedist for evaluation of shoulder pain. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in October, 2020. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) Antiviral drugs are medicines that fight against viruses in the human body by impeding the infection process. Antivirals are commonly used to treat HIV/AIDS, influenza, herpes, and hepatitis B and C. The antiviral, Remdesivir, which was originally developed to fight Ebola, is now being used to treat COVID-19. On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains how antivirals work to shorten the course of the disease. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Richard Weinshilboum, M.D. Host: Darryl S. Chutka, M.D. In a similar way to how anesthesia changed the practice of surgery, pharmacogenomics will produce a similar change in how we prescribe medications. Listen in to world-renowned expert Dr. Richard Weinshilboum discuss the evolution of the field and how advances are accelerating its application at the bedside. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in September, 2020. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Patrick G. Dean, M.D. Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar) Transplants are identified as nonelective surgeries, and transplant patients have faced urgent medical needs during the COVID-19 pandemic. "Our practice, like many others across the country, did slow down in March and April of this year," says Dr. Patrick Dean, a Mayo Clinic transplant surgeon. "Patients and providers were concerned ― appropriately so ― about what would happen with this pandemic and whether it would be safe to have a transplant or for that matter any health care that wasn't absolutely emergent." In this Mayo Clinic Q&A podcast, Dr. Dean talks about taking care of transplant patients; overcoming surgery challenges during the pandemic; the increased risks transplant patients have of developing SARS-CoV-2, the virus that causes COVID-19, because of compromised immune systems; and the important need for COVID-19 testing. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Eoin Flanagan, M.B., B.Ch. (@EoinFlanagan14) Host: Darryl S. Chutka, M.D. (@ChutkaMD) This episode will review the following topics regarding Multiple Sclerosis (MS): Common presenting symptoms Risk factors, including the association of MS and vitamin D Typical pathologic changes found in patients The difference between the relapsing and progressive forms of MS Laboratory and imaging studies which are helpful in confirming a diagnosis Established and new treatment options available Available useful resources for patients with MS: Mayo Clinic website on Multiple Sclerosis National MS Society Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in September, 2020. Guest: Angela C. Mattke, M.D. (@DrAngelaMattke) Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar) The COVID-19 pandemic continues to create challenges, including returning to school with hybrid learning modules for children. There are also anxieties and uncertainties to navigate, while trying to follow COVID-19 guidelines. In this "Mayo Clinic Q&A" podcast, Dr. Angela Mattke, a Mayo Clinic pediatrician and host of #AskTheMayoMom, talks about the concerns her patients have, and what important things parents and caregivers should take into consideration when helping children stay healthy. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded on September 14, 2020. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Danielle Stiepan Once a vaccine to prevent COVID-19 is approved, there will be logistics to consider. For example, who will receive the vaccine first, and how can the supply chain safely deliver the vaccine to 330 million Americans and potentially more than 7 billion people worldwide? In addition, multiple vaccines may be brought to market within weeks to months of each other, confusing consumers. On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains the challenges of rolling out a COVID-19 vaccine. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Bithika M. Thompson, M.D. Host: Darryl S. Chutka, M.D. Dr. Bithika Thompson discusses the recognition and treatment of pre-diabetes, individualizing glycemic control goals for patients based on a series of variables, and recent advances in technology for monitoring that help to decrease the burden of care. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

To register for notification when the 94th Annual Clinical Reviews Course opens visit: https://mayocl.in/2GvecAd Guest: Stephen L. Kopecky, M.D. With underlying cardiovascular disease as the most lethal comorbidity to have in association with COVID-19, what have we learned about how SARS-CoV-2 affects the heart and what correlation is seen between patients with cardiometabolic disorders and preventative health measures? Dr. Stephen Kopecky shares lessons learned for all cardiologists, all caregivers, and all patients. “The cardiovascular risk profile that we use from the American College of Cardiology, from the American Heart Association, looks at hypertension, looks at smoking, looks at diabetes, and looks at lipids. That risk profile predicts cardiovascular complications. So it not only predicts disease but it predicts the complications of COVID infection.” AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in September, 2020. Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, covers the latest news on the COVID-19 pandemic. Dr. Poland gives an update on progress towards a vaccine for COVID-19, discusses therapies for treating the virus and shares research on how effective face masks and physical distancing are in fighting the spread of the disease. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in August, 2020. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Craig N. Sawchuk, Ph.D., L.P. (@CraigSawchukPhD) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) The start of a new school year is always a time that’s filled with excitement and anxiety. This year, COVID-19 is making back to school even more challenging for kids, teachers and parents. Whether in person, online or a hybrid approach, this school year will be different for students and staff. How can you and your child have a healthy mindset for this school year? On the Mayo Clinic Q&A podcast, Dr. Craig Sawchuk, chair of the Division of Integrated Behavioral Health at Mayo Clinic, shares helpful tips and strategies to be resilient and handle the challenges of a school year during the COVID-19 pandemic. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in August, 2020. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Nipunie S. Rajapakse, M.D., M.P.H. (@nrajapakseMD) Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar) Whether in person, online or a hybrid model of education, families and school districts are planning for how to safely teach students during the COVID-19 pandemic. No matter which plan is chosen by communities, this school year will be challenging. On the Mayo Clinic Q&A podcast, Dr. Nipunie Rajapakse, a pediatric infectious disease specialist at Mayo Clinic, discusses how students, teachers and staff can use public health measures already in place to minimize the risk of exposure to the virus and reduce community spread of COVID-19. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Alison J. Bruce, M.B., Ch.B. & Shane A. Shapiro, M.D. Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) Androgenic alopecia can have a significant impact on women across a spectrum of age. The psychological and social impact of hair thinning and hair loss can significantly decrease quality of life. Dr. Alison Bruce breaks down different types of hair loss, who’s a candidate, and new therapies on the horizon. Dr. Shane Shapiro will discuss the application of regenerative medicine to this condition and how platelet rich plasma has demonstrated efficacy at regrowing hair. Deeper Dive: A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women doi: 10.1097/DSS.0000000000002168 Episode transcript: https://mcdn.podbean.com/mf/web/d545pv/Ep_185-Regenerative_Medicine_Takes_on_Hair_Loss.pdf Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Answers from the Lab and was originally published June 30, 2020. Guest: John R. Mills, Ph.D. Host: Bobbi S. Pritt, M.D. (@ParasiteGal) John Mills, Ph.D., is the co-director of the Neuroimmunology Laboratory at Mayo Clinic and the scientist who oversaw the development and validation of the new neutralizing antibody assay. Today he joins us to explain what the neutralizing antibody assay is, why it is different than other COVID-19 tests, and the science and innovation behind these efforts. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Answers from the Lab and was originally published June 25, 2020. Guest: William G. Morice, II M.D., Ph.D. (@moricemdphd) Host: Bobbi S. Pritt, M.D. (@ParasiteGal) William Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and President of Mayo Clinic Laboratories, joins the Answers from the Lab podcast for his weekly leadership update. In this episode, Dr. Morice discusses the future of testing for COVID-19, predicting who would be at the highest risk for severe disease, and challenges with existing diagnostics. AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd

Guest: Daniel B. Saris, M.D., Ph.D. (@sarisnl) Host: Darryl S. Chutka, M.D. (@ChutkaMD) With over 12 million outpatient visits annually in association with knee pain, it’s a common presentation in primary care. Dr. Daniel Saris discusses what questions we should be asking our patients, when to order imaging studies, and the common causes of pain broken down by age demographic. He’ll also discuss stem cell therapy, who is a good candidate, and who isn’t. Episode transcript: https://mcdn.podbean.com/mf/web/cjj292/Ep_183-Sorting_Out_Knee_Pain_and_Treatment_Opportunities.pdf Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.